NegroR, FormosoG, MangieriT, PezzarossaA, DazziD, HassanH. 2006. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab, 91:2587–2591.
2.
NegroR, SchwartzA, GismondiR, TinelliA, MangieriT, Stagnaro-GreenA. 2010. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab, 95:1699–1707.
3.
Stagnaro-GreenA, RomanSH, CobinRH, el-HarazyE, Alvarez-MaranyM, DaviesTF. 1990. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA, 264:1422–1425.
4.
ThangaratinamS, TanA, KnoxE, KilbyMD, FranklynJ, CoomarasamyA. 2011. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. British Medical Journal, 342:2260.
Stagnaro-GreenA, AbalovichM, AlexanderE, AziziF, MestmanJ, NegroR, NixonA, PearceEN, SoldinOP, SullivanS, WiersingaW. 2011. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid, 21:1081–1125.
HollowellJG, StaehlingNW, FlandersWD, HannonWH, GunterEW, SpencerCA, BravermanLE. 2002. Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)J Clin Endocrinol Metab, 87:489–499.
10.
LadensonPW, SingerPA, AinKB, BagchiN, BigosST, LevyEG, SmithSA, DanielsGH. 2000. American Thyroid Association Guidelines for detection of thyroid dysfunction. Arch Intern Med, 160:1573–1575.
11.
DosiouC, BarnesJ, SchwartzA, NegroR, CrapoLM, Stagnaro-GreenA. 2011. Cost effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. Abstract presented at the 81st Annual Meeting of the American Thyroid Association, Indian Wells, CA, October 26–30, Abstract # 10.
